Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Humanised IgG1 monoclonal antibody against human KIR3DL2

EU orphan designation number: EU/3/14/1322   
Active ingredient: Humanised IgG1 monoclonal antibody against human KIR3DL2
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: Innate Pharma S.A.
117 avenue de Luminy, BP 30191, 13276 Marseille Cedex 09, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/08/2014 Orphan designation EMA/OD/084/14 (2014)6128 of 22/08/2014
8/04/2015 Corrigendum (2015)2367 of 1/04/2015